Griffith Donald J. 4
4 · Sonnet BioTherapeutics Holdings, Inc. · Filed Apr 8, 2022
Insider Transaction Report
Form 4
Griffith Donald J.
DirectorChief Financial Officer
Transactions
- Tax Payment
Common Stock
2022-04-08$0.37/sh−4,507$1,655→ 106,186 total - Award
Common Stock
2021-12-15+15,000→ 110,693 total
Footnotes (2)
- [F1]On December 15, 2021, the Reporting Person was granted 15,000 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold by the Issuer in multiple transactions at prices ranging from $0.3673 to $0.3800 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.